Evidence map›Paper›PMID 41635307›Full record

ArticleBiosafety and health2025

Epidemiological characteristics of human adenovirus infections in China, 2020-2023.

Chongyang Li, Yitong Lin, Naiying Mao, Yixuan Gao, Ying Liu, Liwei Sun, Hui Zhang, Jin Xu, Maozhong Li, Feng Zhang and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biosafety and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Chongyang LiNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Yitong LinNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Naiying MaoNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Yixuan GaoNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Ying LiuNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Liwei SunPrecision Medicine Research Center, Children's Hospital of Changchun, Changchun 130061, China.
Hui ZhangGansu Provincial Center for Disease Control and Prevention, Key Laboratory of Infectious Diseases of Gansu Province, Lanzhou 730050, China.
Jin XuHenan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China.
Maozhong LiInstitute for Immunization and Prevention, Beijing Center for Disease Prevention and Control, Academy for Preventive Medicine, Institute of Tuberculosis Control Research and Prevention, Beijing 100013, China.
Feng ZhangLaboratory of Viral Diseases, Qingdao Municipal Centre for Disease Control and Prevention, Qingdao Institute of Prevention Medicine, Qingdao 266000, China.
Xiaoqing LiuJiangxi Provincial Center for Disease Control and Prevention, Nanchang 330029, China.
Linqing ZhaoLaboratory of Virology, Beijing Key Laboratory of Etiology of Viral Diseases in Children, Capital Institute of Pediatrics, Beijing 100020, China.
Bing ZhuVirus Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510120, China.
Ye ChenShenyang Center for Disease Control and Prevention, Shenyang City, Shenyang 110100, China.
Min MuSchool of Public Health, Anhui University of Science and Technology, Huainan 231131, China.
Xiaoling TianInstitute for Immunization Program, Inner Mongolia Autonomous Region Centre for Disease Control and Prevention, The Academy of Preventive Medicine Sciences in Inner Mongolia Autonomous Region, Hohhot 010031, China.
Hongmei XuDepartment of Infection Diseases, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
Chaoyang HuangHunan Provincial Centre for Disease Control and Prevention, Changsha 410153, China.
Zhong LiShandong Center for Disease Prevention and Control, Shandong Provincial Key Laboratory of Intelligent Monitoring, Early Warning, Prevention and Control for Infectious Diseases, Jinan 250014, China.
Jing XuShaanxi Provincial Centre for Disease Control and Prevention, Xi'an 710054, China.
Zhenguo GaoInstitute of Acute Infectious Disease Prevention and Control, Xinjiang Uygur Autonomous Region Center for Disease Control and Prevention, Urumqi 830002, China.
Yali JinNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Chunyu ZhuNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Aili CuiNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Baicheng XiaNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Yan ZhangNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Zhen ZhuNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To better understand the epidemiological characteristics of human adenovirus (HAdV) infections in China during and after the coronavirus disease 2019 (COVID-19) pandemic, respiratory specimens were collected from 17,562 enrolled patients with acute respiratory infections (ARIs) in 14 sentinel surveillance provinces during 2020-2023. Eight common respiratory viruses were detected using commercially available nucleic acid detection kits. HAdV-positive cases were statistically analyzed for detection rates, geographic distribution, seasonal patterns, demographic characteristics, and co-infection status. The results of this study showed that the overall HAdV detection rate was 5.09 % (894/17,562) during 2020-2023, with a gradual decrease in the annual detection rate from 6.66 % in 2020 to 3.89 % in 2022 and a rebound in 2023 (5.19 %). The overall HAdV detection rate was significantly higher in the southern region (6.15 %) than in the northern region (4.76 %) (

Indexed as

Epidemiological characteristicHuman adenovirusRespiratory infection

Identifiers

PMID41635307
PMCPMC12861750

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.